Company Filing History:
Years Active: 2022
Title: The Innovative Journey of Nils Griebnow
Introduction
Nils Griebnow, an accomplished inventor based in Dormagen, Germany, is notable for his contribution to the field of pharmaceutical sciences. With a focus on developing new compounds for medical applications, Griebnow's work showcases the intersection of innovation and health.
Latest Patents
Nils Griebnow holds a patent for "Anthelmintic quinoline-3-carboxamide derivatives," which includes novel quinoline compounds with significant potential for treating helminth infections. The patent outlines the general formula for these compounds, methods for their preparation, and their applications in pharmaceutical compositions aimed at the prevention and control of such diseases. This invention not only emphasizes his innovative capabilities but also highlights the importance of developing effective treatments in veterinary medicine.
Career Highlights
Nils Griebnow has established himself as a key player at Bayer Animal Health GmbH, where he utilizes his expertise to advance animal health solutions. His patent reflects a commitment to innovation in the pharmaceutical sector, particularly in developing new therapeutic options. Griebnow's career trajectory is marked by his dedication to enhancing health outcomes through his inventive work.
Collaborations
At Bayer Animal Health GmbH, Griebnow collaborates with talented professionals including Walter Hübsch and Johannes Köbberling. These collaborations are essential in fostering a creative environment where innovative ideas can flourish and lead to groundbreaking inventions in animal health.
Conclusion
Nils Griebnow's contribution to the field of pharmaceutical sciences through his innovative patented work highlights his role as a significant inventor. Based in Dormagen and associated with Bayer Animal Health GmbH, his dedication to developing new treatments for helminth infections showcases the vital blending of science and innovation. As he continues to work alongside talented colleagues, his future endeavors hold promise for significant advancements in animal health and welfare.